Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Withdrawn 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Lymphoid 1

Conditions

Mucositis 1Lymphoma 1Hodgkin Disease 1

Interventions

Therapeutics 2apraglutide 1angiotensin I (1-7) 1Psychology, Positive 1Psychiatric Rehabilitation 1Methods 1High-Energy Shock Waves 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hodgkin Disease × apraglutide × Other × Clear all
NCT03417765 2024-10-24

Safety, Tolerability, PK/PD of FE 203799 in Adults With Lymphomas

VectivBio AG

Phase 1/2 Withdrawn
LymphoidOther

Hodgkin Disease, Lymphoma, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡